Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dacarbazine with Melatonin or Metformin in Disseminated Melanoma
NCT02190838Phase 2Terminated
- Sponsor
- N.N. Petrov National Medical Research Center of Oncology
- Start
- Apr 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin, melatonin in melanoma, sponsored by N.N. Petrov National Medical Research Center of Oncology. Started Apr 2014; status: terminated.
02
Drugs
metforminmelatonin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02190838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02190838.